MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis

Todd Boren1, Yin Xiong, Ardeshir Hakam

  • 1H. Lee Moffitt Cancer Center & Research Institute, Divisions of Gynecologic Surgical Oncology, Tampa, FL 33612, USA. Todd.Boren@moffitt.org

Abstract

Insights

This study identifies microRNAs (miRNAs) and messenger RNAs (mRNAs) linked to endometrial cancer development. Integrating miRNA and mRNA data reveals key pathways involved in endometrial carcinogenesis.

Area of Science:

  • Molecular Biology
  • Genomics
  • Cancer Research

Background:

  • Global messenger RNA (mRNA) expression changes in endometrial cancer are known.
  • Post-transcriptional regulatory mechanisms, such as microRNAs (miRNAs), require further investigation in endometrial carcinogenesis.
  • miRNAs are small non-coding RNAs influencing cell function by modulating mRNA activity.

Purpose of the Study:

  • To identify microRNAs (miRNAs) and messenger RNAs (mRNAs) associated with endometrial cancer.
  • To explore the role of miRNAs in endometrial carcinogenesis.
  • To integrate miRNA and mRNA expression data to understand endometrial pathogenesis.

Main Methods:

  • Expression profiling of 335 unique miRNAs and 22,000 mRNA genes in 61 endometrial specimens (cancers, normal endometrium, atypical hyperplasia).
  • Analysis of differentially expressed mRNAs, miRNAs, and predicted miRNA-mRNA targets.
  • Pathway analysis to evaluate the functional relevance of identified genes.

Main Results:

  • Thirteen miRNAs and 90 mRNAs were significantly associated with endometrial cancer development.
  • Twenty-six of the differentially expressed mRNAs were predicted targets of the identified miRNAs.
  • Pathway analysis indicated the involvement of these genes in cell death, growth, proliferation, and carcinogenesis.

Conclusions:

  • Identified specific miRNAs and mRNAs implicated in endometrial cancer.
  • Demonstrated the utility of integrating miRNA and mRNA data for pathway discovery.
  • Highlighted the potential of this approach to uncover novel genes in endometrial pathogenesis.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...